A detailed history of Verity Asset Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Verity Asset Management, Inc. holds 1,754 shares of ABBV stock, worth $312,229. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,754
Previous 1,638 7.08%
Holding current value
$312,229
Previous $281 Million 23.32%
% of portfolio
0.13%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$163.84 - $199.33 $19,005 - $23,122
116 Added 7.08%
1,754 $347 Million
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $22,908 - $26,752
148 Added 9.93%
1,638 $281 Million
Q1 2024

May 28, 2024

SELL
$159.82 - $182.1 $159 - $182
-1 Reduced 0.07%
1,490 $271 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $205,161 - $231,060
1,491 New
1,491 $231 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $23.1 Million - $28.7 Million
175,133 New
175,133 $115,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Verity Asset Management, Inc. Portfolio

Follow Verity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verity Asset Management, Inc. with notifications on news.